Biotech Valuation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation

CRSP 56.87

-2.3%

Dec 5 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Biomaven who wrote (963)	4/17/2000 8:25:00 PM
From: Harold Engstrom	of 52153

Peter, nice extract from TSC. That pretty much sums it up. I can't understand momentum buying or selling, but can of course recognize it. In the past, I've been able to take advantage of it when a company like Sepracor has gone on saled due to its effects. Or Biogen in 1997. If everyone has their finger on the hair trigger to sell, that is a sad commentary on their belief that they have created a company that either has value or is a strong value-creating machine. So what is on sale today that will likely appreciate significantly in 2-5 years? I think Sepracor is looking good again (due to decline and FTC ruling combo); PCYC looks good due to promising pipeline and good financing (pipe at ~$75); BTRN looks good - pipeline, SCS investment, and solid balance sheet (another pipe at higher valuations). I also took a chance on BLSI - $90MM market cap and an NDA for $75MM indication (early stage PD) and $500MM indication (ADD) looming.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next